Voices: Therapeutic Dose

No Easy Answers for Drug Pricing

Improving manufacturing efficiencies offers most concrete possibilities for cost reduction

By Jerry Martin, pharmaceutical and life sciences consultant, PMMI
Feb 21, 2017

Drug pricing is a complex and controversial topic that does not have an easy or particularly straightforward remedy. The cost of medicine is a function of R&D and process development/validation costs, the cost of regulatory approval and manufacturing costs — with manufacturing costs accounting for the smallest portion of the burden.

Read More